A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis
NCT01093118
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
120
Enrollment
INDUSTRY
Sponsor class
Stopped
Business decision
Conditions
Distal Subungual Onychomycosis
Interventions
DRUG:
TMI-358
DRUG:
MMI-467
Sponsor
Talima Therapeutics, Inc.